The timing of treatment relative to injury is essential when interpreting a wound-healing experiment. An early postoperative intervention does not necessarily model treatment of a longstanding clinical fistula. Primary study
What was studied
In rats with surgically created rectovaginal fistulas, early BPC-157 treatment was associated with improved defects and leakage measures, fewer adhesions, and less obstruction. Microscopic and gross assessments were performed across several postoperative time points. Primary report
Our appraisal: distinguish prevention of persistence from late repair
Starting an intervention soon after a defect is created can affect the initial healing environment. Treating a mature, recurrent, or disease-associated tract is a different challenge. Describing both as simply “fistula treatment” hides an important translation gap.
The combination of structural and functional outcomes is helpful. An intact-looking surface and absence of abnormal passage are not identical observations, so their agreement is more informative than either alone. A full assessment still needs predefined criteria and blinded evaluation where feasible.
Adhesion and obstruction findings broaden the biological picture but should not be treated as independent patient benefits. They occur within one animal experiment and may share underlying processes. Counting every favorable endpoint as a separate confirmation would overstate the evidence.
Repeated postoperative assessments also require attention to the experimental unit. Measurements taken from multiple sections or repeated observations are not automatically independent animals. The statistical design should match the level of allocation and sampling.
This report supports further preclinical investigation of the model. It does not demonstrate that a peptide can replace surgical assessment or established management of a rectovaginal fistula in people, nor does it establish long-term recurrence prevention.
Frequently asked questions
Was treatment delayed until a chronic tract developed?
The described treatment began early after surgery.
Which species was studied?
Rats.
Were only tissue photographs assessed?
No; leakage and other outcomes were included.
Does early healing prove prevention of recurrence?
No; that requires appropriate later follow-up.
Are multiple tissue sections independent subjects?
Not when they come from the same animal.
Does this establish a nonsurgical human treatment?
No.
What is the key translation question?
Whether an early experimental response applies to established human disease.